Clinical trials: Early Rheumatoid Arthritis
Rheumatoid Arthritis
Early Rheumatoid Arthritis Lung Disease Study
Extra-articular (outside of joints) disease occurs in approximately 50% of rheumatoid arthritis (RA) patients, with the lung being a common site of involvement.
- Trial name
- NCT03192267
- Where
- United States
- Volunteers
- 125 people
- Sponsor
- University of Nebraska
Rheumatoid Arthritis, Psoriatic Arthritis
GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden
GÖTHA- The early arthritis and psoriasis study of Region Västra Götaland, Sweden - is a longitudinal observational study, which will prospectively and in parallel follow patients with newly diagnosed rheumatoid arthritis (RA…
- Conditions
- Rheumatoid Arthritis, Psoriatic Arthritis, Arthritis, Psoriasis
- Trial name
- GOTHA (NCT04190758)
- Testing
- Care as usual
- Where
- Sweden
- Volunteers
- 5,100 people, healthy volunteers welcome
- Sponsor
- Vastra Gotaland Region
Rheumatoid Arthritis
A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926
This multicenter, open-label, single arm, long-term extension study will evaluate the safety and efficacy of RoActemra/Actemra (tocilizumab) in patients with early moderate to severe rheumatoid arthritis who completed the WA19926…
- Trial name
- NCT01730456
- Testing
- tocilizumab [RoActemra/Actemra]
- Where
- North Macedonia
- Volunteers
- 13 people
- Sponsor
- Hoffmann-La Roche
Rheumatoid Arthritis
Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis
The purpose of the study is to evaluate the effectiveness of adalimumab in combination with methotrexate compared to methotrexate alone on work disability in subjects with early rheumatoid arthritis
- Trial name
- NCT00234845
- Testing
- adalimumab, methotrexate
- Where
- United States
- Volunteers
- 148 people
- Sponsor
- Abbott
Early Rheumatoid Arthritis
Early RA MRI Early Intensive Treatment Study
To compare the effectiveness of two treatment strategies in early rheumatoid arthritis (ERA), namely the delayed usual care and early intensive care, in Hong Kong.
- Trial name
- NCT01762176
- Testing
- Protocolized intensive treatment, Usual care
- Where
- China
- Volunteers
- 163 people
- Sponsor
- Chinese University of Hong Kong
Rheumatoid Arthritis
CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis
This trial will test the hypothesis that the administration of CF101, a novel anti-inflammatory agent, to patients with rheumatoid arthritis will relieve signs and symptoms of the disease.
- Trial name
- NCT02647762
- Testing
- CF101 1 mg, CF101 2 mg, MTX
- Where
- 35 sites in Bosnia and Herzegovina, Canada and 5 more
- Volunteers
- 244 people
- Sponsor
- Can-Fite BioPharma
Juvenile Chronic Polyarthritis, Juvenile Idiopathic Arthritis
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
The purpose of this study is to compare two aggressive drug regimens for children with poly-juvenile idiopathic arthritis (JIA) and extended oligo JIA.
- Conditions
- Juvenile Chronic Polyarthritis, Juvenile Idiopathic Arthritis, Juvenile Rheumatoid Arthritis
- Trial name
- NCT00443430
- Testing
- methotrexate, methotrexate - etanercept - prednisolone arm
- Where
- 15 sites in United States
- Volunteers
- 85 people
- Sponsor
- Seattle Children's Hospital
Early Rheumatoid Arthritis, Rheumatoid Arthritis
INCMNSZ - Rheumatoid Arthritis Cohort
Identify Rheumatoid Arthritis patients diagnose within first 12 months since the beginning of the disease related symptoms. Initiate proper treatment according to international standards in order to achieve remission/low disease…
- Trial name
- IRAC (NCT03389711)
- Testing
- DMARD´s and multidisciplinary treatment
- Where
- Mexico
- Volunteers
- 237 people
- Sponsor
- National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Erosive Disease in Early Rheumatoid Arthritis
Prediction of Erosive Disease in Early Rheumatoid Arthritis (RA) by Ultrasound and Cartilage Biodegradation Markers
Multicenter, prospective, open-label, cohort study. Primary objective: Determination of the predictive value of US alone and in combination with cartilage biodegradation markers on radiographic progression (change in Ratingen…
- Trial name
- NCT02464384
- Testing
- Venipuncture, ultrasound, MRI, x-ray
- Volunteers
- 24 people
- Sponsor
- University of Zurich
Rheumatoid Arthritis
Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
The purpose of this study is to examine changes in immune cells and proteins in response to treatment with two approved therapies for Rheumatoid arthritis (RA), abatacept versus adalimumab, both given in combination with…
- Trial name
- NCT02557100
- Testing
- Abatacept, Adalimumab, Methotrexate
- Where
- 28 sites in United States, Canada and 1 more
- Volunteers
- 80 people
- Sponsor
- Bristol-Myers Squibb
Rheumatoid Arthritis
Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis
To compare the effects of the combination of ETN and MTX to MTX alone on radiographic change and clinical disease activity in subjects with early RA over 12 months.
- Trial name
- NCT00195494
- Testing
- Etanercept, Methotrexate
- Where
- United States
- Volunteers
- 542 people
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
Arthritis, Rheumatoid
COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA
In the Care in Rheumatoid Arthritis (CareRA) trial (NCT01172639) about 70% of early RA patients are in remission at the 2 year evaluation point independent of the combination scheme used.
- Trial name
- CareRA2020 (NCT03649061)
- Testing
- Etanercept 50 MG/ML, Leflunomide 10 milligram (MG)
- Where
- 19 sites in Belgium
- Volunteers
- 276 people
- Sponsor
- P. Verschueren
Arthritis, Reactive, Arthritis, Rheumatoid
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
This study will evaluate the 2-5 year outcome of a cohort of 250 patients with early synovitis, who were recruited into protocol 94-AR-0194 (The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis).
- Conditions
- Arthritis, Reactive, Arthritis, Rheumatoid, Synovitis
- Trial name
- NCT00001679
- Where
- United States
- Volunteers
- 250 people
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Rheumatoid Arthritis, Polyarthritis
Targeting Synovitis in Early Rheumatoid Arthritis
Patients with rheumatoid arthritis are at risk of developing permanent joint damage and disability. This study hopes to identify the most effective way of using existing arthritis medication to minimise the chances of developing…
- Trial name
- TaSER (NCT00920478)
- Testing
- Musculoskeletal Ultrasound, 28 Joint Disease Activity Score
- Where
- 3 sites in United Kingdom
- Volunteers
- 110 people
- Sponsor
- NHS Greater Glasgow and Clyde
Arthritis, Rheumatoid
Modified Zhiwang Decoction Combined With Methotrexate in the Treatment of Early Rheumatoid Arthritis
The aim of this study is to evaluate the effectiveness and safety of Modified Zhiwang Decoction in combination with methotrexate for the treatment of early RA patients and a parallel-group, single-center randomized controlled…
- Trial name
- NCT05508815
- Testing
- Modified Zhiwang Decoction Combined with methotrexate, Methotrexate
- Where
- China
- Volunteers
- 150 people
- Sponsor
- Beijing University of Chinese Medicine
Sjögren Syndrome, Pulmonary Hypertension
Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome
According to the literature available pulmonary hypertension is present in 12 to 23% of patients suffering from Sjögren Syndrome. However epidemiological data are based on non-invasive measurements using echocardiography.
- Trial name
- NCT02752269
- Where
- Austria
- Volunteers
- 86 people
- Sponsor
- Medical University of Graz
Rheumatoid Arthritis
An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis
This open-label, single arm, multicenter long-term extension study of WA19926 evaluated the safety and efficacy of tocilizumab (RoActemra/Actemra) in participants with moderate to severe rheumatoid arthritis who completed the…
- Trial name
- NCT01664598
- Testing
- Tocilizumab
- Where
- 12 sites in Russia
- Volunteers
- 49 people
- Sponsor
- Hoffmann-La Roche
Rheumatoid Arthritis
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis
This is an observational prospective, multicenter study. The aim of the study is to evaluate how the Italian population of patients are treated with early aggressive RA, defined by the Italian Society of Rheumatology Guidelines…
- Trial name
- ARPA (NCT00267852)
- Testing
- as clinical practice
- Where
- 16 sites in Italy
- Volunteers
- 152 people
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
Early Rheumatoid Arthritis
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
The purpose of the study is to assess the safety and efficacy of adalimumab in combination with methotrexate in patients with recent onset rheumatoid arthritis (RA), and to assess the long-term safety and maintenance of efficacy…
- Trial name
- PREMIER (NCT00195663)
- Testing
- Adalimumab, Methotrexate
- Where
- 123 sites in United States, Australia and 17 more
- Volunteers
- 799 people
- Sponsor
- AbbVie (prior sponsor, Abbott)
Rheumatoid Arthritis (RA
Pix-Risk: Early Detection of Rheumatoid Arthritis Via the DETECTRA Platform
The goal of this clinical trial is to learn if a remote monitoring application called DETECTRA can help doctors diagnose rheumatoid arthritis earlier in people who are at risk of developing the disease.
- Trial name
- Pix-Risk (NCT07825233)
- Testing
- DETECTRA, Standard of Care (SOC)
- Where
- 5 sites in Austria, Denmark and 2 more
- Volunteers
- 142 people
- Sponsor
- Centre Hospitalier Universitaire Vaudois